PI4KAP2
Putative phosphatidylinositol 4-kinase alpha-like protein P2
Also known as: PI4P2_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for PI4KAP2 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
592 residues, UniProt reviewed canonical sequence.
>A4QPH2|PI4KAP2
1 MTVEQKFGLF SAEIKEADPL AASEASQPKP CPPEVTPHYI WIDFLVQRFE IAKYCSSDQV
61 EIFSSLLQRS MSLNIGRAKG SMNRHVAAIG PRFKLLTLGL SLLHADVVPN ATIRNVLREK
121 IYSTAFDYFS CPPKFPTQGE KRLREDISIM IKFWTAMFSD KKYLTASQLV PPADIGDLLE
181 QLVEENTGSL SGPAKDFYQR GFDFFNKITN VSAVIKPYPK GDERKKACLS ALSEVTVQPG
241 CSLPSNPEAI VLDVDYKSGT PMQSAAKAPY LAKFKVKRCG VSELEKEGLR CRSDSEDECS
301 TQEADGQKIS WQAAIFKLGD DCRQKSYWGA RMPTDRILRL PASQDMLALQ IIDLFKNIFQ
361 LVGLDLFVFP YRVVATAPGC GVIECIPDCT SRDQLGRQTD FGMYDYFTRQ YGDESTLAFQ
421 QARYNFIRSM AAYSLLLFLL QIKDRHNGNI MLDKKGHIIH IDFGFMFESS PGGNLGWEPD
481 IKLTDEMVMI MGGKMEATPF KWFMEMCVQA TWLCGEPGPY MDVVVSLVTI MLDTGLPCFR
541 GQTIKLLKHR FSPNMTEREA ANFIMKVIQS CFLSNRSRTY NMIQYYQNDI PYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PI4KAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
- Phosphatidylinositol 3-/4-kinase, catalytic domain
- Protein kinase-like domain superfamily
- Phosphatidylinositol 3-/4-kinase
- Phosphatidylinositol 3-/4-kinase, conserved site
- Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily
- PI4-kinase, N-terminal
- Phosphatidylinositol 3- and 4-kinase
- PI4-kinase N-terminal region
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PI4KAP2 as an antibody target. Whether an autoantibody or antibody against PI4KAP2 could matter depends on whether native PI4KAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PI4KAP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PI4KAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...